Sanofi signs malaria research alliance
May 5, 2011Research and Development Medicines for Malaria Venture, Sanofi-Aventis, malaria
Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …
Prostate cancer drug Zytiga gains US approval
May 5, 2011Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer
Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …
Plavix sales plummet in England
May 5, 2011Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel
GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …
Debiopharm and Yale University to develop autoimmune treatment
May 5, 2011Research and Development Debiopharm, Yale University
Debiopharm is teaming up with researchers at Yale University to develop Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory …
Pfizer sales flat as Lipitor revenues decline
May 4, 2011Sales and Marketing Pfizer
Pfizer’s sales decreased slightly in the first quarter after rising revenues in specialty care and emerging markets failed to offset …
Hospitals face greater than expected savings target
May 4, 2011Monitor, NHS reforms, foundation trusts
Hospitals are being asked to nearly double their savings target as a result of the increasingly tough economic environment they …
Avastin as effective as Lucentis in eye disease
May 4, 2011Research and Development Lucentis, avastin, off label, wet AMD
Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …
Astellas adds senior executives to global development team
May 4, 2011Research and Development appointment, research and development
Astellas Pharma has made four new senior appointments to its US-based global development team. Former Eli Lilly vice president of …
Service Insight: Due diligence in emerging markets for clinical development
May 4, 2011Research and Development Service Insight, Talking Point, research and development
SERVICE INSIGHT Currently, the pharma industry is experiencing an unprecedented wave of blockbuster drug patent expiries. There is a lack …
Contract research news in brief
May 4, 2011Research and Development contract research, cros, research and development
This week’s CRO news roundup includes Omnicare CR and LAB Research changing hands, Q1 financials for ICON and PPD and …
UK pharma reassured over dealings with health bodies
May 3, 2011Medical Communications, Sales and Marketing 2011 ABPI Code, Code of Practice, medical communications, risk-sharing
UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …
US approval for Boehringer’s diabetes drug Tradjenta
May 3, 2011Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly
Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …
Strides Arcolab facility gets the nod from FDA
May 3, 2011Manufacturing and Production Pfizer, distribution issues
Indian pharmaceutical manufacturer Strides Arcolab has been given a green light from the FDA for a facility in Bangalore that’s …
Cephalon accepts Teva’s $6.8 billion white knight bid
May 3, 2011Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics
Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …
Teva’s Irvine facility gets FDA green light
May 3, 2011Manufacturing and Production FDA, Teva, manufacturing compliance
Teva Pharmaceutical Industries has said that an injectables facility in the USA, shut down last April after quality control problems, …
Watermeadow Medical expands
May 3, 2011Medical Communications appointment, medical communications
Oxfordshire, UK-based medical communications consultancy Watermeadow Medical has welcomed 11 new members of staff to its UK roster.Chief among them …
Bosch boosts pharma processing ops with Oystar purchases
May 3, 2011Manufacturing and Production Bosch, Hüttlin, Manesty, Oystar, pharma manufacturing
Bosch Packaging Technology is planning to expand its position in the pharmaceutical processing equipment sector with the purchase of two …
Mitsui gets bigger in Japan with contract manufacturing buy
April 28, 2011Manufacturing and Production Mitsui, contract manufacturing
Japanese company Mitsui & Co has agreed to buy MBS Co, a company set up earlier this month to house …
Caliber opens ‘world’s largest plant production facility’
April 28, 2011Manufacturing and Production Biopharmaceuticals, Caliber Biotherapeutics, G-Con LLC, biopharmaceutical manufacturing
A new facility dedicated to manufacturing biopharmaceuticals in plant cell culture – claimed to be the largest of its type …
Healthcare comms is changing fast – but hold onto this principle
April 28, 2011Medical Communications advertising, communications, digital marketing, marketing
Having spent the last forty-plus years in and around the pharma industry, it’s an understatement to say I have seen …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
